A carregar...
Intravenous immunoglobulin treatment in multiple sclerosis: A prospective, rater‐blinded analysis of relapse rates during pregnancy and the postnatal period
BACKGROUND: Multiple sclerosis (MS) affects predominantly young women. Currently available disease‐modifying drugs have neither been approved during pregnancy nor nursing. AIMS: Evaluating the effect of treatment with intravenous immunoglobulin (IVIg) in MS patients with desire to have a baby. METHO...
Na minha lista:
| Publicado no: | CNS Neurosci Ther |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6436593/ https://ncbi.nlm.nih.gov/pubmed/29858532 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12985 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|